Article
What changed
On Jan. 5, acting CDC Director Jim O’Neill signed a decision memo that took effect immediately. Vaccines against measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Hib, pneumococcal disease, HPV and chickenpox remain routine for all children. Influenza, rotavirus, COVID-19, hepatitis A and B and meningococcal vaccines moved to shared clinical decision-making, and several, including RSV antibodies and hepatitis B, are now recommended routinely only for higher-risk groups. CMS Administrator Mehmet Oz said all vaccines the CDC currently recommends will stay covered by insurance without cost sharing.
In a related step, CMS told states on Dec. 30 that they no longer must report childhood vaccination rates for Medicaid and CHIP quality measurement, though they may do so voluntarily.
How clinicians responded
The response from physician groups was swift. The American Academy of Pediatrics called the change dangerous and unnecessary and said it will publish its own schedule. The American Academy of Family Physicians said its recommendations have not changed. The AMA criticized the lack of expert and public input. By Jan. 19, hundreds of medical and public health organizations had signed a letter asking Congress for oversight and for action to protect coverage, including through the Vaccines for Children program. Those groups cite estimates that childhood vaccines given from 1994 to 2023 prevented about 32 million hospitalizations.
Decisions for health system leaders
- Choose and document a standard. Chief medical officers should decide whether the system follows the CDC schedule, the AAP and AAFP schedules, or a defined hybrid, and record the clinical rationale.
- Update the EHR. Order sets, best practice alerts and patient reminders are built around the prior schedule. Make deliberate changes rather than leaving each clinic to adapt on its own.
- Confirm coverage. Work with payer contracting and pharmacy teams to verify that vaccines moved to shared decision-making remain reimbursed, and watch for changes in public program supply.
- Support clinicians in conversations. Shared decision-making takes more visit time. Give clinicians consistent talking points and patient materials.
- Keep measuring. Even if state reporting becomes voluntary, track immunization rates internally. Falling uptake will show up later as preventable admissions during outbreaks and respiratory seasons.
Federal policy could shift again through Congress, the courts or further agency action. Systems that set a clear standard now will be better placed to adjust.
Archive entry for Jan 19, 2026, added Nov. 11, 2026.
Sources
- CDC revises childhood immunization schedule, shifting several vaccines to shared decision-making (Infection Control Today, Jan 5, 2026)
- CDC updates childhood immunization schedule; routine list narrowed to 11 diseases (Medical Economics, Jan 5, 2026)
- More than 200 organizations denounce childhood vaccine schedule change (Drug Topics, Jan 19, 2026)

